A leading Covid-19 vaccine under development in China showed undetermined results about its level of defense, although researchers remain optimistic that the prospect can be amongst a lineup of efficient vaccines utilized to eliminate the pandemic.
In early-stage clinical trials, Sinovac Biotech Ltd.’s CoronaVac vaccine was revealed to induce antibodies in the human body within 28 days of the first immunization, according to results published in the Lancet medical journal today. The level of antibodies, nevertheless, were lower than …
Comments
Post a Comment